2015
DOI: 10.1007/978-3-319-17121-0_92
|View full text |Cite
|
Sign up to set email alerts
|

Polymodal Sensory Integration in Retinal Ganglion Cells

Abstract: An animal's ability to perceive the external world is conditioned by its capacity to extract and encode specific features of the visual image. The output of the vertebrate retina is not a simple representation of the 2D visual map generated by photon absorptions in the photoreceptor layer. Rather, spatial, temporal, direction selectivity and color “dimensions” of the original image are distributed in the form of parallel output channels mediated by distinct retinal ganglion cell (RGC) populations. We propose t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
17
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
6
1

Relationship

4
3

Authors

Journals

citations
Cited by 15 publications
(17 citation statements)
references
References 35 publications
0
17
0
Order By: Relevance
“…Given that IOP reduction represents a highly effective treatment of both hypertensive and normal-tension versions of the disease 1 , the novel prodrug analog described here may provide safe and effective glaucoma therapy by targeting the pressure sensor, a major currently unmet need in the clinical treatment of glaucoma 2 . The potential for protecting RGCs from mechanical stress by TRPV4 inhibition 21 63 offers additional impetus to explore possible solutions for combined IOP-lowering and neuroprotective treatments to prevent vision loss in glaucoma.…”
Section: Discussionmentioning
confidence: 99%
“…Given that IOP reduction represents a highly effective treatment of both hypertensive and normal-tension versions of the disease 1 , the novel prodrug analog described here may provide safe and effective glaucoma therapy by targeting the pressure sensor, a major currently unmet need in the clinical treatment of glaucoma 2 . The potential for protecting RGCs from mechanical stress by TRPV4 inhibition 21 63 offers additional impetus to explore possible solutions for combined IOP-lowering and neuroprotective treatments to prevent vision loss in glaucoma.…”
Section: Discussionmentioning
confidence: 99%
“…Hypercholesterolemic retinas show a striking resemblance to the effects of excessive TRPV4 activation (reactive gliosis, increased permeability of the retinal microvascular endothelial barrier, pathological glial swelling and RGC degeneration) (Jo et al, ; Phuong et al, ; Ryskamp et al, ). Accordingly, PLA2 blockers suppressed both Müller glial TRPV4 activation (Ryskamp et al, ) and the reactive response induced by hypercholesterolemia and diabetes mellitus (Acharya et al, ) whereas cholesterol‐lowering drugs reduced the risk for contracting glaucoma (Marcus et al, ) which might involve TRPV4 overactivation (Križaj, ). Hence, TRPV4 channels could represent an auxiliary target in proinflammatory dyslipidemic pathologies.…”
Section: Discussionmentioning
confidence: 99%
“…RGCs are typically categorized by their light response and serendipitous expression of molecular markers ( Zeng and Sanes, 2017 ) but this ignores the possibility that RGC might also be classified based on their responsiveness to the local milieu, which continually bombards them with mechanical, cardiovascular and immune signals. We know that non-canonical non-synaptic sensory inputs can dramatically impact the function and survival of RGC subtypes ( Muller et al, 2014 ; Duan et al, 2015 ; Križaj, 2016 ; Ou et al, 2016 ) yet the lack of knowledge about the transduction mechanisms that mediate them hampers physiological insight and treatment in diseases such as glaucoma, diabetic retinopathy, ischemia, and traumatic ocular injury.…”
Section: Introductionmentioning
confidence: 99%